China SXT Pharmaceuticals Inc Strategic Asset Allocation Index
China SXT Pharmaceuticals Inc strategic asset allocation index. China SXT Pharmaceuticals Inc (SXTC) has a Strategic Asset Allocation Index of 9.1% as of September 2022. Strategic assets (PP&E of $1.36 Million plus long-term investments of $-) total $1.36 Million, measured against net assets of $14.89 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check China SXT Pharmaceuticals Inc (SXTC) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of China SXT Pharmaceuticals Inc (2016–2022)
Strategic asset allocation index of China SXT Pharmaceuticals Inc from 2016 to 2022. This chart shows how China SXT Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of September 2022, the index stands at 9.1%, representing strategic assets of $1.36 Million against net assets of $14.89 Million USD.
China SXT Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2016–2022)
China SXT Pharmaceuticals Inc strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for China SXT Pharmaceuticals Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see China SXT Pharmaceuticals Inc (SXTC) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 9.7% | $1.59 Million | $1.59 Million | $- | $16.42 Million | ▼ -1.5 pp |
| 2021 | 11.2% | $1.79 Million | $1.79 Million | $- | $15.96 Million | ▼ -9.0 pp |
| 2020 | 20.2% | $1.90 Million | $1.90 Million | $- | $9.40 Million | ▲ +4.0 pp |
| 2019 | 16.3% | $1.81 Million | $1.81 Million | $- | $11.11 Million | ▼ -29.0 pp |
| 2018 | 45.3% | $1.49 Million | $1.49 Million | $- | $3.29 Million | ▲ +19.1 pp |
| 2017 | 26.2% | $485.29K | $485.29K | $- | $1.85 Million | ▼ -31.7 pp |
| 2016 | 57.9% | $430.08K | $430.08K | $- | $742.77K | — |